1. Home
  2. ELTX vs KOSS Comparison

ELTX vs KOSS Comparison

Compare ELTX & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • KOSS
  • Stock Information
  • Founded
  • ELTX 2011
  • KOSS 1953
  • Country
  • ELTX United States
  • KOSS United States
  • Employees
  • ELTX N/A
  • KOSS N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • ELTX Health Care
  • KOSS Consumer Staples
  • Exchange
  • ELTX Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • ELTX 49.7M
  • KOSS 63.0M
  • IPO Year
  • ELTX 2021
  • KOSS N/A
  • Fundamental
  • Price
  • ELTX $4.16
  • KOSS $7.34
  • Analyst Decision
  • ELTX Buy
  • KOSS
  • Analyst Count
  • ELTX 2
  • KOSS 0
  • Target Price
  • ELTX $10.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • KOSS 183.8K
  • Earning Date
  • ELTX 11-07-2024
  • KOSS 11-08-2024
  • Dividend Yield
  • ELTX N/A
  • KOSS N/A
  • EPS Growth
  • ELTX N/A
  • KOSS N/A
  • EPS
  • ELTX N/A
  • KOSS N/A
  • Revenue
  • ELTX N/A
  • KOSS $12,265,069.00
  • Revenue This Year
  • ELTX N/A
  • KOSS N/A
  • Revenue Next Year
  • ELTX N/A
  • KOSS N/A
  • P/E Ratio
  • ELTX N/A
  • KOSS N/A
  • Revenue Growth
  • ELTX N/A
  • KOSS N/A
  • 52 Week Low
  • ELTX $2.96
  • KOSS $2.27
  • 52 Week High
  • ELTX $11.45
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • KOSS 50.17
  • Support Level
  • ELTX $4.05
  • KOSS $7.00
  • Resistance Level
  • ELTX $4.89
  • KOSS $7.83
  • Average True Range (ATR)
  • ELTX 0.28
  • KOSS 0.44
  • MACD
  • ELTX -0.06
  • KOSS -0.01
  • Stochastic Oscillator
  • ELTX 27.37
  • KOSS 32.26

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: